These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17286614)

  • 1. Lessons from the CAESAR Study: calcineurin inhibitors--can't live with them and can't live without them.
    Kaplan B; Budde K
    Am J Transplant; 2007 Mar; 7(3):495-6. PubMed ID: 17286614
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of low-dose calcineurin inhibitors on acute rejection and graft survival.
    Altaca G; Berber I; Aydin C; Titiz I
    Transplant Proc; 2002 Sep; 34(6):2079-80. PubMed ID: 12270320
    [No Abstract]   [Full Text] [Related]  

  • 3. Which calcineurin inhibitor is preferred in renal transplantation: tacrolimus or cyclosporine?
    Vanrenterghem YF
    Curr Opin Nephrol Hypertens; 1999 Nov; 8(6):669-74. PubMed ID: 10630811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin use and rapid withdrawal of calcineurin inhibitors in pediatric renal transplantation.
    Vilalta R; Vila A; Nieto J; Callís L
    Transplant Proc; 2003 Mar; 35(2):703-4. PubMed ID: 12644102
    [No Abstract]   [Full Text] [Related]  

  • 5. Calcineurin inhibitors: short-term friend, long-term foe?
    Matas AJ
    Clin Pharmacol Ther; 2011 Aug; 90(2):209-11. PubMed ID: 21772297
    [No Abstract]   [Full Text] [Related]  

  • 6. Calcineurin inhibitors in pediatric renal transplant recipients.
    Filler G
    Paediatr Drugs; 2007; 9(3):165-74. PubMed ID: 17523697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcineurin inhibitors: 40 years later, can't live without ..
    Azzi JR; Sayegh MH; Mallat SG
    J Immunol; 2013 Dec; 191(12):5785-91. PubMed ID: 24319282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A calcineurin antagonist-free induction immunosuppression strategy for delayed graft function in renal transplantation.
    Hong JC; Kahan BD
    Transplant Proc; 2001; 33(1-2):1271-2. PubMed ID: 11267288
    [No Abstract]   [Full Text] [Related]  

  • 9. Calcineurin-inhibitors in renal transplantation. Too precious to be abandoned.
    Ponticelli C
    Nephrol Dial Transplant; 2000 Sep; 15(9):1307-9. PubMed ID: 10978383
    [No Abstract]   [Full Text] [Related]  

  • 10. Steroid sparing strategies in renal transplantation.
    Grinyó JM
    Nephrol Dial Transplant; 2005 Oct; 20(10):2028-31. PubMed ID: 16105871
    [No Abstract]   [Full Text] [Related]  

  • 11. Calcineurin inhibitors in renal transplantation: what is the best option?
    Tanabe K
    Drugs; 2003; 63(15):1535-48. PubMed ID: 12887261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Improved immunosuppression leads to better kidney transplantations].
    Ekberg H
    Lakartidningen; 2012 Sep 26-Oct 9; 109(39-40):1739-42. PubMed ID: 23097879
    [No Abstract]   [Full Text] [Related]  

  • 13. Tacrolimus as cornerstone immunosuppressant in kidney transplantation.
    Berloco P; Rossi M; Pretagostini R; Sociu-Foca Cortesini N; Cortesini R
    Transplant Proc; 2001; 33(1-2):994-6. PubMed ID: 11267161
    [No Abstract]   [Full Text] [Related]  

  • 14. Sirolimus to replace calcineurin inhibitors? Too early yet.
    Cravedi P; Ruggenenti P; Remuzzi G
    Lancet; 2009 Apr; 373(9671):1235-6. PubMed ID: 19362662
    [No Abstract]   [Full Text] [Related]  

  • 15. Daclizumab: novel biologic immunoprophylaxis for prevention of acute rejection in renal transplantation.
    Vincenti F
    Transplant Proc; 1999 Sep; 31(6):2206-7. PubMed ID: 10500546
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of newer monoclonal antibodies in renal transplantation.
    Vincenti F
    Transplant Proc; 2001; 33(1-2):1000-1. PubMed ID: 11267163
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic rejection in pediatric renal transplantation: where are we?
    Tejani A
    Pediatr Transplant; 2000 May; 4(2):83-5. PubMed ID: 11272612
    [No Abstract]   [Full Text] [Related]  

  • 18. [Toward an evidence-based immunosuppression].
    Pascual J
    Nefrologia; 2001; 21(6):524-5; discussion 526-7. PubMed ID: 11881421
    [No Abstract]   [Full Text] [Related]  

  • 19. Histopathology of calcineurin inhibitor-induced nephrotoxicity.
    Davies DR; Bittmann I; Pardo J
    Transplantation; 2000 Jun; 69(12 Suppl):SS11-3. PubMed ID: 10910257
    [No Abstract]   [Full Text] [Related]  

  • 20. Calcineurin inhibitor sparing immunosuppressive regimens in kidney allograft recipients.
    Baczkowska T; Durlik M
    Pol Arch Med Wewn; 2009 May; 119(5):318-25. PubMed ID: 19579814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.